Category: Fetus
Poster Session IV
Data conflict on whether fetoscopic laser surgery (FLS) for twin-to-twin transfusion syndrome (TTTS) has higher rates of morbidity and mortality when performed earlier in gestation. We sought to estimate complication rates across gestational ages (GA).
Study Design: This is a secondary analysis of prospectively collected data on all patients with monochorionic diamniotic twins with TTTS that underwent FLS between 2011 and 2022 at a single center. Patients were divided into 2-week epochs by GA of FLS. Demographic, ultrasound, and operative characteristics were compared across epochs. Rates of preterm premature rupture of membranes < 34 wks (PPROM), GA of delivery, overall survival and days of maternal hospitalization were compared across epochs. Latency following PPROM was also compared using Kaplan-Mejer curves.
Results:
555 patients underwent FLS for TTTS during the study period. Stage III disease was more common at 16 – 20 wks GA (Table, p < 0.01). Cervical length was also shorter at greater GA (p < 0.01) and larger (i.e. 12 Fr) operative cannulas were more commonly used (p < 0.01). The rates of PPROM < 1 wk from FLS and overall PPROM were higher in the 16 – 18 week epoch (A, p < 0.01). However, GA of delivery was similar across all epochs (B, p = 0.71) even when considering only cases with PPROM (C, p = 0.80). Latency periods following PPROM were inversely proportional to GA at FLS (D, p < 0.01). There were no differences in the total time of maternal hospitalization (mean = 8.35 days, p = 0.31). Survival across all gestational ages was similar, however dual survival was lower for FLS performed at 16 – 18 wks compared to all other epochs (61.1% vs. 79.2%, p < 0.01).
Conclusion:
FLS prior to 18 weeks is associated with greater rates of PPROM, but with similar GA at delivery and longer latency when PPROM does occur. Lower survival at 16 – 18 weeks is likely associated with greater incidence of advanced disease, not PPROM and earlier delivery. Hesitancy in performing FLS at 16 – 18 wks GA may not be warranted.
Clifton O. Brock, MD
Fetal Intervention
Allina Healthcare
Edina, Minnesota, United States
Eric P. Bergh, MD
Assistant Professor
Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth)
Houston, Texas, United States
Edgar Hernandez Andrade, MD
Department of Obstetrics, Gynecology and Reproductive Sciences McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth)
Houston, Texas, United States
Ramesha Papanna, MD, MPH
Professor
Department of Obstetrics, Gynecology and Reproductive Sciences McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth)
Houston, Texas, United States
Anthony Johnson, DO
Professor
Division of Fetal Intervention, The Fetal Center at Children's Memorial Hermann Hospital, Department of Obstetrics, Gynecology and Reproductive Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth)
Houston, Texas, United States